Outputs (6)

The use of nanotechnology in cardiovascular disease (2018)
Journal Article
Chandarana, M., Curtis, A., & Hoskins, C. (2018). The use of nanotechnology in cardiovascular disease. Applied Nanoscience, 1607-1619. https://doi.org/10.1007/s13204-018-0856-z

Cardiovascular diseases claim a number of lives globally; many of which are preventable. With the increase in diets that consist of high saturated fat, salt, and sugar, people often living sedentary lifestyles, and a rise in cases of obesity, the inc... Read More about The use of nanotechnology in cardiovascular disease.

A Novel PAA Derivative with Enhanced Drug Efficacy in Pancreatic Cancer Cell Lines (2018)
Journal Article
Alsuraifi, A., Kong Thoo Lin, P., Curtis, A., Lamprou, D., & Hoskins, C. (2018). A Novel PAA Derivative with Enhanced Drug Efficacy in Pancreatic Cancer Cell Lines. Pharmaceuticals, https://doi.org/10.3390/ph11040091

Nanoparticles have been shown to be effective drug carriers in cancer therapy. Pancreatic cancer forms dense tumours which are often resistant to drug molecules. In order to overcome such multidrug resistance, new drug entities, novel delivery system... Read More about A Novel PAA Derivative with Enhanced Drug Efficacy in Pancreatic Cancer Cell Lines.

Stimuli Responsive Polymeric Systems for Cancer Therapy. (2018)
Journal Article
Curtis, A., Lamprou, D., Hoskins, C., & Alsuraifi, A. (2018). Stimuli Responsive Polymeric Systems for Cancer Therapy. Pharmaceutics, https://doi.org/10.3390/pharmaceutics10030136

Nanoscale polymers systems have dominated the revolution of drug delivery advancement. Their potential in the fight against cancer is unrivalled with other technologies. Their functionality increase, targeting ability and stimuli responsive nature ha... Read More about Stimuli Responsive Polymeric Systems for Cancer Therapy..

Dual Acting Polymeric Nano-Aggregates for Liver Cancer Therapy (2018)
Journal Article
Al-Shakarchi, W., Alsuraifi, A., Curtis, A., & Hoskins, C. (2018). Dual Acting Polymeric Nano-Aggregates for Liver Cancer Therapy. Pharmaceutics, https://doi.org/10.3390/pharmaceutics10020063

Liver cancer treatments are often hindered by poor drug physicochemical properties, hence there is a need for improvement in order to increase patient survival and outlook. Combination therapies have been studied in order to evaluate whether increase... Read More about Dual Acting Polymeric Nano-Aggregates for Liver Cancer Therapy.

Combined effect of anticancer agents and cytochrome C decorated hybrid nanoparticles for liver cancer therapy (2018)
Journal Article
Al-Shakarci, W., Alsuraifi, A., Abed, M., Abdullah, M., Hoskins, C., Richardson, A., & Curtis, A. (2018). Combined effect of anticancer agents and cytochrome C decorated hybrid nanoparticles for liver cancer therapy. Pharmaceutics, 48. https://doi.org/10.3390/pharmaceutics10020048

Hepatocellular carcinoma is an aggressive form of liver cancer that displays minimal symptoms until its late stages. Unfortunately, patient prognosis still remains poor with only 10% of patients surviving more than five years after diagnosis. Current... Read More about Combined effect of anticancer agents and cytochrome C decorated hybrid nanoparticles for liver cancer therapy.

Application of Nanoparticle Technologies in the Combat against Anti-Microbial Resistance (2018)
Journal Article
Curtis, A., Kumar, M., & Hoskins, C. (2018). Application of Nanoparticle Technologies in the Combat against Anti-Microbial Resistance. Pharmaceutics, https://doi.org/10.3390/pharmaceutics10010011

Anti-microbial resistance is a growing problem that has impacted the world and brought about the beginning of the end for the old generation of antibiotics. Increasingly, more antibiotics are being prescribed unnecessarily and this reckless practice... Read More about Application of Nanoparticle Technologies in the Combat against Anti-Microbial Resistance.